SHC (Sotera Health Company) Stock Financials & Earnings | Market Cap Arena

SHC (Sotera Health Company) Stock Financials & Earnings | Market Cap Arena

SHCSotera Health Company

Mkt Cap$4B

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Revenue (TTM)$1.2B

Net Income (TTM)$78M

EPS (TTM)$0.27

Free Cash Flow (TTM)$147M

Gross Margin55.5%

Op. Margin33.8%

Net Margin6.7%

FCF Margin12.6%

P/S Ratio (TTM)3.6x

P/E Ratio (TTM)53.1x

YoY Rev Growth+5.7%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$221M	$112M	$33M
Q2 23	$255M	$140M	$63M
Q3 23	$263M	$146M	$76M
Q4 23	$310M	$180M	$104M
Q1 24	$248M	$127M	$53M
Q2 24	$277M	$153M	$77M
Q3 24	$285M	$158M	$81M
Q4 24	$290M	$164M	$87M
Q1 25	$255M	$135M	$57M
Q2 25	$294M	$167M	$88M
Q3 25	$311M	$178M	$111M
Q4 25	$303M	$166M	$136M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	4.2x	—
Q2 23	4.2x	—
Q3 23	4.2x	—
Q4 23	3.9x	80.5x
Q1 24	3.8x	75.4x
Q2 24	3.8x	103.2x
Q3 24	3.7x	58.5x
Q4 24	3.8x	93.2x
Q1 25	3.7x	166.7x
Q2 25	3.7x	172.2x
Q3 25	3.6x	74.6x
Q4 25	3.6x	53.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$34M	-$11M
Q2 23	-$337M	-$390M
Q3 23	$42M	-$10M
Q4 23	$113M	$48M
Q1 24	$10M	-$25M
Q2 24	$61M	$19M
Q3 24	$96M	$59M
Q4 24	$56M	-$10M
Q1 25	$56M	$36M
Q2 25	$57M	$26M
Q3 25	$70M	$33M
Q4 25	$103M	$52M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$45M
Q2 23	$53M
Q3 23	$52M
Q4 23	$65M
Q1 24	$35M
Q2 24	$42M
Q3 24	$36M
Q4 24	$66M
Q1 25	$20M
Q2 25	$31M
Q3 25	$36M
Q4 25	$51M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-6.8%	+2.2%
Q2 23	-4.3%	-1.6%
Q3 23	+5.8%	+0.8%
Q4 23	+23.3%	+7.7%
Q1 24	+12.5%	+4.2%
Q2 24	+8.3%	+4.0%
Q3 24	+8.5%	+9.6%
Q4 24	-6.5%	-1.5%
Q1 25	+2.6%	+1.3%
Q2 25	+6.4%	+3.1%
Q3 25	+9.1%	-2.4%
Q4 25	+4.6%	-17.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$7M	3.3%
Q2 23	$8M	3.3%
Q3 23	$8M	3.2%
Q4 23	$8M	2.6%
Q1 24	$9M	3.5%
Q2 24	$10M	3.7%
Q3 24	$10M	3.4%
Q4 24	$8M	2.8%
Q1 25	$0	0.0%
Q2 25	$8M	2.8%
Q3 25	$8M	2.6%
Q4 25	$8M	2.5%

OpEx Breakdown

Quarter	SG&A
Q1 23	$62M
Q2 23	$60M
Q3 23	$54M
Q4 23	$60M
Q1 24	$58M
Q2 24	$61M
Q3 24	$62M
Q4 24	$62M
Q1 25	$63M
Q2 25	$69M
Q3 25	$63M
Q4 25	$58M

Revenue Segments

Quarter	Product	Service
Q1 23	$6M	$215M
Q2 23	$29M	$226M
Q3 23	$36M	$227M
Q4 23	$72M	$238M
Q1 24	$22M	$226M
Q2 24	$39M	$238M
Q3 24	$47M	$239M
Q4 24	$51M	$239M
Q1 25	$31M	$224M
Q2 25	$37M	$257M
Q3 25	$56M	$256M
Q4 25	$44M	$259M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$648M	$0	$648M
Q2 23	$263M	$0	$263M
Q3 23	$245M	$0	$245M
Q4 23	$296M	$0	$296M
Q1 24	$261M	$0	$261M
Q2 24	$246M	$0	$246M
Q3 24	$307M	$0	$307M
Q4 24	$277M	$0	$277M
Q1 25	$304M	$0	$304M
Q2 25	$332M	$0	$332M
Q3 25	$301M	$0	$301M
Q4 25	$346M	$0	$346M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	283M	+0.9%
Q2 23	283M	+0.1%
Q3 23	281M	-0.7%
Q4 23	283M	+0.8%
Q1 24	284M	+0.3%
Q2 24	285M	+0.2%
Q3 24	286M	+0.4%
Q4 24	285M	-0.2%
Q1 25	284M	-0.5%
Q2 25	286M	+0.8%
Q3 25	287M	+0.3%
Q4 25	286M	-0.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$273K	3K
FY 21	$310K	3K
FY 22	$335K	3K
FY 23	$350K	3K
FY 24	$367K	3K
FY 25	$388K	3K